FMS

Fresenius Medical Care AG & Co. KGaA

Healthcare Medical Care Facilities NYSE

About the company

Fresenius Medical Care has established itself as a global leader in the field of dialysis, providing life-sustaining treatment to a staggering number of patients worldwide. With over 345,000 patients receiving dialysis care from their vast network of more than 4,100 clinics, the company has an exceptional reach and impact on the healthcare industry. As the largest dialysis company in the world, Fresenius Medical Care offers not only essential services but also a wide range of products that are vital to the dialysis process. They manufacture and supply dialysis machines, dialyzers, and concentrates, which are essential components in delivering life-saving treatments. This comprehensive approach allows Fresenius to control and streamline the entire dialysis process, ensuring the highest level of quality and integration. With a significant presence in the global market, Fresenius Medical Care commands a substantial portion, approximately 35%, of the dialysis products market. This market dominance gives the company a competitive edge, allowing them to leverage economies of scale and negotiate favorable contracts with suppliers, thereby enhancing their profitability. While Fresenius Medical Care's dialysis services form the core of its business and generate approximately 80% of its revenue, the remaining 20% is derived from its product offerings. These products not only complement the services provided but also contribute significantly to the company's bottom line due to their higher profit margins. This diversified revenue stream ensures the company's overall financial stability and longevity in the market. In addition to dialysis services and products, Fresenius Medical Care has expanded its operations to include care coordination and ancillary services. These services focus on helping patients navigate the complex healthcare system, coordinating their care, and providing comprehensive support for their ongoing treatment and well-being. By offering these additional services, Fresenius Medical Care distinguishes itself as a complete healthcare provider, dedicated to the holistic needs of its patients. Fresenius Medical Care's commitment to technological advancement and innovation sets it apart in the dialysis industry. Continuously striving to improve patient outcomes and the quality of care, the company invests heavily in research and development. This focus on innovation has resulted in the introduction of cutting-edge dialysis machines, improved dialyzers, and more efficient dialysis concentrates. By incorporating the latest technologies, Fresenius Medical Care not only ensures the highest standard of care but also positions itself as a trendsetter in the field. With its global network, comprehensive service offerings, and continuous investment in innovation, Fresenius Medical Care has solidified its position as a powerhouse in the dialysis industry. The company's commitment to providing exceptional care and products to its patients has not only saved countless lives but also set a benchmark for the standards of dialysis treatment worldwide. As the demand for dialysis services continues to rise, Fresenius Medical Care is poised to meet the needs of patients around the globe and maintain its dominant position in the market.

Website: https://www.freseniusmedicalcare.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1345 peers in sector

Metric FMS Sector median Vs. industry
P/E 11.02 20.13 ↓ Below average
EPS 1.91 USD -1.14 USD ↑ Above average
Dividend yield 4.14% 0.00% ↑ Above average
Profit margin 4.88% 0.00% ↑ Above average
ROE 7.85% -58.89% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care has established itself as a global leader in the field of dialysis, providing life-sustaining treatment to a staggering number of patients worldwide. With over 345,000 patients receiving dialysis care from their vast network of more than 4,100 clinics, the company has an exceptional reach and impact on the healthcare industry. As the largest dialysis company in the world, Fresenius Medical Care offers not only essential services but also a wide range of products that are vital to the dialysis process. They manufacture and supply dialysis machines, dialyzers, and concentrates, which are essential components in delivering life-saving treatments. This comprehensive approach allows Fresenius to control and streamline the entire dialysis process, ensuring the highest level of quality and integration. With a significant presence in the global market, Fresenius Medical Care commands a substantial portion, approximately 35%, of the dialysis products market. This market dominance gives the company a competitive edge, allowing them to leverage economies of scale and negotiate favorable contracts with suppliers, thereby enhancing their profitability. While Fresenius Medical Care's dialysis services form the core of its business and generate approximately 80% of its revenue, the remaining 20% is derived from its product offerings. These products not only complement the services provided but also contribute significantly to the company's bottom line due to their higher profit margins. This diversified revenue stream ensures the company's overall financial stability and longevity in the market. In addition to dialysis services and products, Fresenius Medical Care has expanded its operations to include care coordination and ancillary services. These services focus on helping patients navigate the complex healthcare system, coordinating their care, and providing comprehensive support for their ongoing treatment and well-being. By offering these additional services, Fresenius Medical Care distinguishes itself as a complete healthcare provider, dedicated to the holistic needs of its patients. Fresenius Medical Care's commitment to technological advancement and innovation sets it apart in the dialysis industry. Continuously striving to improve patient outcomes and the quality of care, the company invests heavily in research and development. This focus on innovation has resulted in the introduction of cutting-edge dialysis machines, improved dialyzers, and more efficient dialysis concentrates. By incorporating the latest technologies, Fresenius Medical Care not only ensures the highest standard of care but also positions itself as a trendsetter in the field. With its global network, comprehensive service offerings, and continuous investment in innovation, Fresenius Medical Care has solidified its position as a powerhouse in the dialysis industry. The company's commitment to providing exceptional care and products to its patients has not only saved countless lives but also set a benchmark for the standards of dialysis treatment worldwide. As the demand for dialysis services continues to rise, Fresenius Medical Care is poised to meet the needs of patients around the globe and maintain its dominant position in the market.
Are Fresenius Medical Care AG & Co. KGaA shares expensive?
The price-to-earnings (P/E) ratio of Fresenius Medical Care AG & Co. KGaA is 11.02 — the share price is 11.02 times the annual profit per share. That is lower than the typical company in the same industry (industry median: 20.13). This is information, not a recommendation. (as of 2026-06-02)
How big is Fresenius Medical Care AG & Co. KGaA?
The market capitalization of Fresenius Medical Care AG & Co. KGaA — the combined value of all its shares — is 11.30 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
The dividend yield of Fresenius Medical Care AG & Co. KGaA is 4.14% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Fresenius Medical Care AG & Co. KGaA belong to?
Fresenius Medical Care AG & Co. KGaA operates in the Healthcare sector, industry: Medical Care Facilities.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120